Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
My Custom Filters
Edit custom filtersResults by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2008 | 1 |
| 2020 | 1 |
| 2026 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation.
Int Immunopharmacol. 2008 Dec 20;8(13-14):1854-8. doi: 10.1016/j.intimp.2008.08.009. Epub 2008 Sep 21.
Int Immunopharmacol. 2008.
PMID: 18789402
However, the underlying mechanisms responsible for antitumor effects of rapamycin remain to be fully elucidated. Here we report that rapamycin can reverse TLR4-triggered resistance of colon cancer cells to oxaloplatin- or doxorubicin-induced …
However, the underlying mechanisms responsible for antitumor effects of rapamycin remain to be fully elucidated. Here we report that …
Corrigendum to "Rapamycin reverses TLR4 signaling-triggered tumor apoptosis resistance by disrupting Akt-mediated Bcl-xL upregulation" [Int. Immunopharmacol. 8 (2008) 1854-1858].
Sun Q, Zheng Y, Liu Q, Cao X.
Sun Q, et al.
Int Immunopharmacol. 2020 Apr;81:106193. doi: 10.1016/j.intimp.2020.106193. Epub 2020 Mar 3.
Int Immunopharmacol. 2020.
PMID: 32139322
No abstract available.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.